A detailed history of Swiss National Bank transactions in Illumina, Inc. stock. As of the latest transaction made, Swiss National Bank holds 472,900 shares of ILMN stock, worth $63.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
472,900
Previous 470,500 0.51%
Holding current value
$63.7 Million
Previous $49.1 Million 25.57%
% of portfolio
0.04%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$105.28 - $135.9 $252,672 - $326,160
2,400 Added 0.51%
472,900 $61.7 Million
Q2 2024

Aug 08, 2024

SELL
$101.05 - $133.57 $505,250 - $667,850
-5,000 Reduced 1.05%
470,500 $49.1 Million
Q1 2024

May 07, 2024

SELL
$127.73 - $147.2 $2.49 Million - $2.87 Million
-19,500 Reduced 3.94%
475,500 $65.3 Million
Q4 2023

Feb 06, 2024

SELL
$92.79 - $142.53 $1.25 Million - $1.92 Million
-13,500 Reduced 2.65%
495,000 $68.9 Million
Q3 2023

Nov 08, 2023

SELL
$128.91 - $192.44 $8.02 Million - $12 Million
-62,200 Reduced 10.9%
508,500 $69.8 Million
Q2 2023

Aug 09, 2023

SELL
$183.43 - $232.67 $9.81 Million - $12.4 Million
-53,500 Reduced 8.57%
570,700 $107 Million
Q1 2023

May 10, 2023

SELL
$193.75 - $232.55 $2.95 Million - $3.53 Million
-15,200 Reduced 2.38%
624,200 $145 Million
Q4 2022

Feb 08, 2023

SELL
$187.24 - $242.74 $7.76 Million - $10.1 Million
-41,447 Reduced 6.09%
639,400 $129 Million
Q3 2022

Nov 09, 2022

SELL
$177.23 - $227.44 $35,446 - $45,488
-200 Reduced 0.03%
680,847 $130 Million
Q2 2022

Aug 09, 2022

BUY
$181.58 - $368.0 $6.88 Million - $13.9 Million
37,900 Added 5.89%
681,047 $126 Million
Q1 2022

May 09, 2022

BUY
$303.87 - $423.8 $26 Million - $36.2 Million
85,500 Added 15.33%
643,147 $225 Million
Q4 2021

Feb 08, 2022

SELL
$347.28 - $421.83 $6.84 Million - $8.31 Million
-19,700 Reduced 3.41%
557,647 $212 Million
Q3 2021

Nov 08, 2021

SELL
$405.61 - $524.84 $7.14 Million - $9.24 Million
-17,600 Reduced 2.96%
577,347 $234 Million
Q2 2021

Aug 06, 2021

BUY
$372.84 - $481.5 $12.6 Million - $16.2 Million
33,734 Added 6.01%
594,947 $282 Million
Q1 2021

May 07, 2021

BUY
$361.28 - $504.76 $3.54 Million - $4.95 Million
9,800 Added 1.78%
561,213 $216 Million
Q4 2020

Feb 05, 2021

SELL
$292.7 - $370.96 $6.09 Million - $7.72 Million
-20,800 Reduced 3.64%
551,413 $204 Million
Q3 2020

Nov 09, 2020

SELL
$268.51 - $400.74 $2.44 Million - $3.65 Million
-9,100 Reduced 1.57%
572,213 $177 Million
Q2 2020

Aug 05, 2020

BUY
$256.46 - $373.01 $2.77 Million - $4.03 Million
10,800 Added 1.89%
581,313 $215 Million
Q1 2020

May 08, 2020

BUY
$209.2 - $335.53 $22.4 Million - $35.9 Million
107,100 Added 23.11%
570,513 $156 Million
Q4 2019

Feb 06, 2020

SELL
$288.29 - $335.49 $6.34 Million - $7.38 Million
-22,000 Reduced 4.53%
463,413 $154 Million
Q3 2019

Nov 12, 2019

BUY
$266.84 - $378.23 $1.62 Million - $2.3 Million
6,068 Added 1.27%
485,413 $148 Million
Q2 2019

Aug 02, 2019

SELL
$300.59 - $368.15 $3.43 Million - $4.2 Million
-11,400 Reduced 2.32%
479,345 $176 Million
Q1 2019

May 10, 2019

BUY
$272.57 - $321.18 $3.52 Million - $4.14 Million
12,900 Added 2.7%
490,745 $152 Million
Q4 2018

Feb 13, 2019

BUY
$272.46 - $366.54 $2.34 Million - $3.15 Million
8,600 Added 1.83%
477,845 $143 Million
Q3 2018

Nov 08, 2018

SELL
$279.04 - $367.06 $4.69 Million - $6.17 Million
-16,800 Reduced 3.46%
469,245 $172 Million
Q2 2018

Aug 09, 2018

BUY
$228.17 - $292.07 $4.04 Million - $5.17 Million
17,700 Added 3.78%
486,045 $136 Million
Q1 2018

May 04, 2018

SELL
$209.54 - $253.91 $14.7 Million - $17.8 Million
-70,300 Reduced 13.05%
468,345 $111 Million
Q4 2017

Feb 07, 2018

BUY
$202.23 - $230.03 $121,338 - $138,018
600 Added 0.11%
538,645 $118 Million
Q3 2017

Nov 03, 2017

BUY
$172.3 - $213.93 $92.7 Million - $115 Million
538,045
538,045 $107 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.2B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.